INVO Fertility, Inc. (IVF)
NASDAQ: IVF · Real-Time Price · USD
1.760
0.00 (0.00%)
At close: Nov 20, 2026, 4:00 PM EST
1.750
-0.010 (-0.57%)
After-hours: Nov 20, 2026, 7:30 PM EST
INVO Fertility Revenue
INVO Fertility had revenue of $2.22M in the quarter ending September 30, 2026, with 26.50% growth. This brings the company's total for the last twelve months to $8.00M, up 15.16% year-over-year. In the year 2025, INVO Fertility had annual revenue of $6.84M with 4.73% growth. That makes INVO Fertility the 38,346th largest company in the world by revenue and 5,030th in the United States.
Revenue (ttm)
$8.00M
Revenue Growth
+15.16%
P/S Ratio
0.26
Revenue / Employee
$190,397
Employees
42
Market Cap
2.10M
Revenue by Segment
- Fertility Clinic Services 6.72M 97.9%
- INVO Cell Device 147.19K 2.1%
Fiscal year ended Dec 31, 2025 See the full INVO Fertility breakdown
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 6.84M | 309.25K | 4.73% |
| Dec 31, 2024 | 6.53M | 3.51M | 116.25% |
| Dec 31, 2023 | 3.02M | 2.20M | 267.38% |
| Dec 31, 2022 | 822.20K | -3.34M | -80.24% |
| Dec 31, 2021 | 4.16M | 3.12M | 301.06% |
| Dec 31, 2020 | 1.04M | -442.93K | -29.92% |
| Dec 31, 2019 | 1.48M | 985.84K | 199.41% |
| Dec 31, 2018 | 494.38K | 212.23K | 75.22% |
| Dec 31, 2017 | 282.15K | 231.24K | 454.30% |
| Dec 31, 2016 | 50.90K | 39.21K | 335.46% |
| Dec 31, 2015 | 11.69K | -4.90K | -29.53% |
| Dec 31, 2014 | 16.59K | -10.48K | -38.71% |
| Dec 31, 2013 | 27.06K | -29.31K | -52.00% |
| Dec 31, 2012 | 56.38K | -15.13K | -21.15% |
| Dec 31, 2011 | 71.50K | 3.86K | 5.70% |
| Dec 31, 2010 | 67.65K | 4.44K | 7.03% |
| Dec 31, 2009 | 63.20K | 25.21K | 66.35% |
| Dec 31, 2008 | 38.00K | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Baird Medical Investment Holdings | 24.49M |
| WORK Medical Technology Group LTD | 10.72M |
| Nuwellis | 9.01M |
| Beyond Air | 8.19M |
| VolitionRx | 3.44M |
| 20/20 Biolabs | 2.00M |
| Co-Diagnostics | 858.89K |
| Nexalin Technology | 277.31K |
IVF News
- 5 days ago - INVO Fertility Reports Third Quarter 2026 Results Highlighting 28% Clinic Revenue Growth and Continued Positive Clinic-Level Adjusted EBITDA - GlobeNewsWire
- 6 days ago - INVO Fertility Quarterly report: Q3 2026 - Filings
- 6 days ago - INVO Fertility Earnings release: Q3 2026 - Filings
- 16 days ago - INVO Fertility Partners with PatientFi to Help Make Fertility Treatment More Affordable - GlobeNewsWire
- 23 days ago - INVO Fertility Inc trading halted, news pending - TheFly
- 25 days ago - INVO Fertility announces 1-for-4 reverse stock split - TheFly
- 25 days ago - INVO Fertility Announces a 1:4 Reverse Stock Split Effective Pre-Market Opening on October 30, 2026 - GlobeNewsWire
- 1 month ago - INVO Fertility to Participate in the Lytham Partners Fall 2026 Investor Conference - GlobeNewsWire